Acroosteolysis-Keloid-Like Lesions-Premature Aging Syndrome

Acroosteolysis-keloid-like lesions-premature aging syndrome is a very rare, inherited connective-tissue disorder. Children look older than their age because the fat under the skin is reduced, the skin is thin and almost see-through, the hair is sparse, and the cheekbones look flat. Many develop thick, raised, scar-like skin growths that look like keloids. Over time, the tips of the finger and toe bones slowly dissolve (acro-osteolysis), which can change nail shape, shorten digits, and cause pain with use. The most up-to-date research shows the usual cause is a single spelling change (mutation) in the PDGFRB gene that keeps the PDGFR-β receptor “switched on,” overstimulating skin and bone cells. Most cases happen de novo (by chance in the child), and the condition tends to follow an autosomal-dominant pattern when inherited. PMC+1UniProtOrpha.net

Acroosteolysis-keloid-like lesions-premature aging syndrome is a very rare genetic disorder in the “progeroid” family (conditions that mimic early aging). Doctors also call it Penttinen syndrome or premature aging syndrome, Penttinen type. People with this condition often look older than their age. They may have thin or translucent skin, less body fat (lipoatrophy), thin hair, and firm, raised scar-like growths on the skin that look like keloids. One key sign on X-rays is acro-osteolysis, which means the tips of the finger and toe bones slowly resorb over time. Many have dental delay, distinctive facial features from childhood, and sometimes eye surface overgrowths (pterygia). The cause is usually a gain-of-function mutation in the PDGFRB gene, which makes a cell-signaling receptor (PDGFR-β) overactive; this drives abnormal skin scarring, fat loss, and bone changes. Orpha.netPMC+1

Another names

This syndrome is also known as: Penttinen syndrome, premature aging syndrome, Penttinen type, PENTT, and Penttinen-aula syndrome. All these names refer to the same clinical picture: a progeroid (premature-aging) appearance with lipoatrophy, thin/transparent skin, keloid-like lesions, and acro-osteolysis. Historically, it was first described as a distinctive progeroid syndrome with characteristic facial features and bone changes; later, genetic studies linked many cases to PDGFRB activation. These aliases appear across rare-disease catalogs and clinical reports and are used interchangeably in the literature. National Organization for Rare Disordersmonarchinitiative.orgPubMed

Types

Doctors do not recognize formal subtypes. In practice, clinicians sometimes group patients by clinical pattern:

• Classic Penttinen pattern: premature-aging look, keloid-like plaques, acro-osteolysis, and lipoatrophy.

• Variant presentations: the same core features plus special findings reported in case series (for example, ocular pterygia, distinctive progressive facial configuration, or early overgrowth in infancy), reflecting how strongly PDGFR-β signaling is activated in different tissues. PubMedWiley Online Library

---

Causes

Important note: this is a genetic condition. The root cause is a PDGFRB gain-of-function mutation. The items below explain how that single genetic change drives the different clinical features in the body.

1. PDGFRB gain-of-function (p.Val665Ala, p.Asn666His and similar): keeps the receptor abnormally active, even without its normal growth-factor signal. This pushes cells to grow, remodel tissue, and send downstream signals continuously. PMC+1

2. Constitutive STAT3/PLCγ signaling: the overactive receptor turns on signaling paths (like STAT3 and PLCγ) that alter skin and bone cell behavior, promoting atrophic skin mixed with keloid-like overgrowth. Mayo Clinic

3. Fibroblast hyper-responsiveness: skin fibroblasts overproduce and mis-organize collagen and matrix, creating thick, raised, keloid-like plaques and scar-like bands in fragile, thin skin. PMC

4. Abnormal wound healing: trivial skin injury can trigger exaggerated scarring because the receptor’s “go” signal does not turn off, so repair overshoots and forms keloid-like tissue. PMC

5. Dermal atrophy and lipoatrophy: PDGFR-β dysregulation disturbs subcutaneous fat and dermal support tissue, making skin thin, translucent, and easily damaged. UniProt

6. Impaired pericyte and small-vessel support: PDGFR-β is crucial for pericytes (vessel-support cells); dysregulation can alter microcirculation, feeding into poor skin quality and slow repair. (Mechanism inferred from PDGFRB biology.) Wikipedia

7. Bone remodeling imbalance at distal phalanges: excessive osteoclast activity and matrix turnover at finger/toe tips drives acro-osteolysis. PMC

8. Altered tendon/soft-tissue remodeling: chronic signaling stiffens soft tissues, leading to contractures and reduced joint range. PubMed

9. Craniofacial growth disturbance: underdeveloped malar bones and midface relate to abnormal mesenchymal signaling during growth, producing the characteristic facial appearance. malacards.org

10. Hair follicle effects: thin/sparse hair reflects disturbed cycling of follicle cells under altered growth-factor signaling. malacards.org

11. Dental development delay: tooth eruption and jaw growth can lag because bone and mesenchyme development are affected. PubMed

12. Ocular surface overgrowth (pterygia): unchecked fibrovascular growth at the eye surface can form pterygia in some patients. PubMed

13. Collagen architecture disarray: excess but poorly organized collagen yields plaques that look like keloids and stiff, tethered skin. PMC

14. Persistent low-grade inflammation: abnormal signaling can keep tissues in a “repair-ready” state that encourages scar overgrowth. PMC

15. Adipocyte differentiation block: PDGFR-β activation can suppress fat cell formation from mesenchymal cells, causing lipoatrophy. (Shown in PDGFRB models.) Wikipedia

16. Matrix metalloproteinase imbalance: matrix breakdown at digit tips may outpace formation, helping explain bone tuft resorption. (Mechanistic inference from acro-osteolysis biology.) BioMed Central

17. Mechanical-stress amplification: tight, thin skin under daily friction or pressure tends to scar abnormally when the pathway is hyperactive. PMC

18. Autosomal-dominant transmission risk: when inherited, a single mutant copy can drive the phenotype in offspring. Most known cases, however, are de novo. PMCUniProt

19. Signal “dose” effect: different PDGFRB variants (or mosaicism) can change how strong and where the pathway is active, shaping severity and features. PMC

20. Pathway cross-talk: PDGFR-β interacts with other growth-factor circuits; broad downstream effects help explain why skin, bone, hair, and eyes can all be involved. Cell

---

Symptoms and signs

1. Prematurely aged look: thin skin, loss of baby fat, and fine hair make a child look older than peers. PMC

2. Lipoatrophy: the fat layer under the skin thins out, especially in the face and limbs, sharpening features and showing veins. PMC

3. Thin, translucent skin: the dermis is atrophic, so the skin looks almost see-through and bruises easily. UniProt

4. Keloid-like plaques: thick, raised, scar-like overgrowths form spontaneously or after minor injury. PMC

5. Acro-osteolysis: X-rays show resorption of the finger/toe tips, which can shorten digits and change nails. malacards.orgBioMed Central

6. Distinctive face: underdeveloped cheekbones, mild proptosis, small jaw, and a “drawn” look progress with age. malacards.org

7. Sparse, thin scalp hair: hair may be fine and reduced in density. malacards.org

8. Contractures and stiff joints: tight skin and soft-tissue changes limit movement, especially in hands/feet. PubMed

9. Skin fragility and easy scarring: minor scratches or piercings can leave large, raised scars. PMC

10. Ocular pterygia (in some): a fleshy wing-shaped growth on the eye surface may appear. PubMed

11. Dental delay/malocclusion: teeth erupt late; bite problems occur due to jaw growth issues. PubMed

12. Hand/foot pain with use: bone loss at tips and soft-tissue tightness can make fine tasks painful.

13. Nail changes: nails may warp, lift, or appear shortened as the distal phalanx remodels.

14. Recurrent skin infections of plaques: thick plaques can crack or ulcerate and then get infected.

15. Psychosocial stress: the visible, progressive nature of the features can affect self-image and social participation.

---

Diagnostic tests

A) Physical examination

1. General inspection: document facial configuration, body fat loss, hair thinning, and overall growth pattern; compare serially over time. PMC

2. Skin exam: map all keloid-like plaques, note triggers (injuries, injections), check for ulceration/infection. PMC

3. Hand/foot exam: look for fingertip tenderness, shortening, and nail contour changes that suggest underlying acro-osteolysis. BioMed Central

4. Joint range-of-motion: measure contractures; track progression to guide therapy needs. PubMed

5. Eye and oral exam: screen for pterygia; assess dental eruption and bite alignment. PubMed

B) Manual/functional tests

6. Grip-pinch assessment: simple dynamometry captures hand function decline as distal phalanges resorb.

7. Fine motor tasks (buttons/peg test): tracks functional impact of fingertip bone loss on daily living.

8. Skin extensibility/pliability check: gentle pinch and glide help judge dermal atrophy/tethering.

9. Foot pressure mapping (if available): shows altered load in toes with osteolysis-related shortening.

(These bedside measures complement imaging and are useful for therapy planning.)

C) Laboratory & pathological tests

10. Targeted genetic testing for PDGFRB: sequencing detects gain-of-function variants (for example, p.Val665Ala or p.Asn666His); results confirm diagnosis and inform inheritance risks. PMC+1

11. Broader progeroid/acro-osteolysis gene panel: helpful when clinical signs are overlapping; helps exclude laminopathies (LMNA/ZMPSTE24) and other syndromes. PMC

12. Skin biopsy of a plaque: shows dermal atrophy with dense, hyalinized collagen in keloid-like lesions; rules out other tumors or inflammatory diseases. PMC

13. Inflammation/metabolic labs (baseline): CBC, CRP/ESR, glucose/lipids; mainly for general health and to plan treatment; no disease-specific pattern is expected.

14. Bone-turnover markers (optional): can provide supportive data on resorption/formation balance in severe acro-osteolysis.

15. Microbiology (when lesions ulcerate): swab culture guides antibiotics if secondary infection occurs.

D) Electrodiagnostic tests

16. Electromyography (EMG) if weakness/contracture is atypical: rules out coincidental neuromuscular disease; not routine but used when symptoms suggest it.

17. Nerve-conduction studies for numbness/tingling: only if sensory complaints raise a question of neuropathy (helps separate unrelated issues).

(These are not core tests for this syndrome, but are sometimes used to clarify unusual symptoms.)

E) Imaging tests

18. Hand/foot radiographs: cornerstone test; show distal tuft resorption and remodeling over time; compare serial films. BioMed Central

19. Skeletal survey (selected cases): looks for other bone changes and excludes alternative causes of acro-osteolysis in children. BioMed Central

20. DEXA (bone density): checks for low bone mass that can coexist and guides fracture prevention.

21. Dental panoramic radiograph: documents jaw and tooth development delays/malocclusion. PubMed

22. High-frequency skin ultrasound or MRI (for plaques): maps thickness and depth of keloid-like tissue to plan procedures.

23. Orbital/ocular imaging (if pterygia problematic): supports surgical planning and rules out other causes of proptosis. PubMed

24. Facial CT (selected): defines midface/cheekbone hypoplasia and airway or dental planning needs. malacards.org

Non-Pharmacological Treatments

A. Physiotherapy & Body-Care Interventions

1. Hand and Foot Joint-Protection Program
   Gentle range-of-motion (ROM) and tendon-gliding exercises help keep small joints supple when bone tips shorten. Splints for night use can hold fingers in a safe position and reduce morning stiffness. Teaching “joint-protection” (using larger joints for tasks, built-up grips, avoiding tight pinching) lowers stress on delicate distal phalanges. Benefits: less pain, fewer contractures, easier daily tasks. Mechanism: movement nourishes cartilage and reduces adhesions; splintage reduces deforming forces. Purpose: preserve function and independence.

2. Custom Orthoses and Off-loading Insoles
   Toe caps, stiff-soled shoes, rocker-bottom soles, or metatarsal pads redistribute pressure away from fragile bone tips and keloid-prone skin. Mechanism: pressure redistribution reduces micro-trauma; off-loading helps ulcer prevention over thin skin. Purpose: protect bone/skin; reduce pain during walking. Benefits: longer walking tolerance and fewer pressure sores.

3. Low-Impact Strength & Balance Training
   Programs using elastic bands, water exercise, stationary cycling, and balance drills reinforce proximal muscle groups without pounding distal bones. Mechanism: muscle loading stimulates bone, improves proprioception, and reduces fall risk. Benefits: better endurance, fewer falls, and secondary bone health support. Purpose: safe lifelong fitness.

4. Edema and Scar Self-Massage (Mechanical Scar Care)
   Light lymphatic massage and circular scar massage soften stiff tissues around keloid-like plaques and improve glide. Mechanism: gentle mechanical load can reorganize collagen cross-links over time; edema control reduces tension on scars. Benefits: comfort, small gains in flexibility. Purpose: adjunct to other scar therapies.

5. Thermal Care: Smart Heat/Cold Use
   Warmth before exercise makes tissues more pliable; brief cold after activity can calm soreness. Avoid extreme cold exposure that can worsen circulation to fingertips. Mechanism: vasomotor effects modulate pain and stiffness. Purpose/Benefit: better exercise tolerance and symptom control.

6. Posture & Spine Care Program
   Because generalized bone changes can alter posture, core stabilization and postural drills (wall slides, chin tucks, hip hinge practice) keep alignment efficient. Mechanism: strengthens spinal stabilizers; reduces compensatory overuse. Benefits: less back/neck pain; improved breathing mechanics. Purpose: long-term comfort.

7. Contracture Prevention Protocol
   Scheduled ROM “snacks” (brief stretches 3–5 times/day), silicone-backed tape to guide skin glide, and night extension splints help resist progressive flexion tightening at fingers/toes. Mechanism: low-load, long-duration stretch remodels connective tissue. Benefit: preserves reach and hand opening for ADLs.

8. Energy Conservation & Ergonomics Coaching
   OT-guided workstation and home-task modifications (lever taps, jar openers, foam handles, voice-to-text) reduce cumulative strain on small joints and fragile skin. Mechanism: biomechanical load management. Benefit: more activity with less symptom flare.

9. Wound-Prevention Foot Care
   Daily inspection, urea-based emollients, careful nail care, and protective socks reduce skin breakdown over bony tips. Podiatry debridement avoids self-injury. Mechanism: moisture balance and pressure control lower ulcer risk. Benefit: fewer infections; faster healing.

10. Sun & UV Protection for Thin Skin
    Broad-spectrum sunscreen, UPF clothing, and shade minimize extra collagen damage and pigment change in translucent skin. Mechanism: UV reduction preserves dermal integrity. Benefit: slower photo-aging, fewer irritations.

11. Compression & Silicone for Scar Areas
    Silicone gel/sheets and gentle pressure garments flatten raised plaques over months by hydrating and reducing tension across scars. Consistent wear matters. Benefit: softer, flatter scars; less itch. Purpose: first-line noninvasive scar care. PMCLippincott JournalsAAFP

12. Breathing & Thoracic Mobility Drills
    Costal expansion and diaphragmatic breathing keep chest wall mobile when soft tissues feel tight. Mechanism: rib mobility reduces postural rigidity; parasympathetic activation calms pain tone. Benefit: easier activity and sleep.

13. Pain-Modulation Physical Techniques
    TENS, graded exposure, and pacing reduce central sensitization. Mechanism: gating and cortical re-framing lower perceived pain. Benefit: more movement with less flare.

14. Fall-Proofing the Home
    Lighting, non-slip mats, rails, and tidy pathways reduce fracture risk when bones are fragile. Mechanism: hazard control. Benefit: fewer injuries.

15. Dental & Jaw Physiotherapy Adjuncts
    Because delayed dentition and facial changes are reported, regular dental care, bite guards if recommended, and gentle jaw ROM help chewing comfort. Benefit: nutrition and oral health support. Wiley Online Library

B. Mind-Body, “Gene-Aware,” and Psychosocial/Educational Therapies

16. Genetic Counseling & Family Education
    Clear teaching on PDGFRB changes, inheritance (often autosomal dominant, sometimes de novo), and realistic expectations helps families plan care, surveillance, and pregnancy decisions. Mechanism: informed choices reduce anxiety; enables early interventions. UniProt

17. CBT-Based Pain Coping & Acceptance Strategies
    Cognitive-behavioral tools (thought reframing, activity pacing, goal setting) reduce pain-related fear and improve participation. Mechanism: changes in appraisal and behavior dampen central pain amplification. Benefit: better mood and function.

18. Mindfulness, Guided Relaxation, and Breathwork
    Simple, daily practices lower sympathetic arousal, improve sleep, and reduce itch perception from keloid-like plaques. Mechanism: autonomic balance; attention shifting. Benefit: calmer days; better adherence to rehab.

19. Sleep Hygiene Coaching
    Regular schedule, cool/dark room, and screen limits improve restorative sleep, which supports tissue repair and pain thresholds. Mechanism: hormonal and immune support during deep sleep. Benefit: more energy for rehab.

20. Nutrition Education for Skin & Bone
    Dietary patterns with adequate protein, calcium, vitamin D, vitamins C and K, magnesium, and omega-3s support collagen and bone metabolism. Mechanism: provides building blocks and co-factors for matrix and bone. Benefit: slower loss of strength and better wound healing.

21. Scar-Care Skills Training
    Hands-on teaching for silicone use, pressure garments, sun care, and what to do after a cut or surgery can prevent keloid expansion. Benefit: patient control over symptoms. PMC

22. Body-Image and Peer-Support Programs
    Changes in appearance can affect self-esteem. Support groups and counseling reduce isolation. Mechanism: social connectedness improves resilience. Benefit: better quality of life.

23. School/Work Accommodations
    Ergonomic pens/keyboard setups, extra time, and task swapping reduce micro-trauma to fingers. Benefit: sustained performance without flares.

24. Heat/Cold Weather Precautions
    Protect fingers from cold (gloves, hand warmers) and avoid extreme heat that worsens swelling/itch. Mechanism: vascular stability prevents pain and skin damage.

25. Vaccination & Infection-Prevention Literacy
    Thin skin and ulcers increase infection risk. Keeping routine vaccines current and early wound care lowers complications. Benefit: fewer setbacks.

---

Drug Treatments

Doses below are illustrative from broader literature and must be individualized by specialists. Penttinen syndrome is ultra-rare; most data come from case reports or from related PDGFRB disorders.

1. Imatinib (PDGFR-β Tyrosine Kinase Inhibitor)
   Class/Purpose: Targeted inhibitor that blocks overactive PDGFR-β signaling—the key driver in many Penttinen cases. Typical dosing used in reports: Adults often 200–400 mg once daily; pediatrics by body surface area (e.g., ~260–340 mg/m²/day) under expert care. Mechanism: Competitively inhibits the ATP-binding site of PDGFR-β, reducing downstream STAT/MAPK signaling. Evidence/Benefits: Case reports/series show improvements in skin, hair growth, contractures, and prevention or slowing of acro-osteolysis and vascular changes in PDGFRB-mutant patients. Side effects: Edema, cramps, cytopenias, GI upset, liver enzyme elevation; requires monitoring. PMCPubMedScienceDirectEurope PMC

2. Dasatinib (TKI)
   Purpose/Mechanism: Broader-spectrum TKI with PDGFR-β activity; sometimes used when imatinib is insufficient or variant-specific resistance exists. Dosing (literature examples): Adult starting 50–100 mg daily; specialist adjusts. Benefits/Notes: Reported adult case with clinical response in Penttinen syndrome. Side effects: Cytopenias, pleural effusion, QT prolongation—close monitoring needed. PubMed

3. Ponatinib (TKI)
   Purpose: Active against certain PDGFRB mutations less sensitive to imatinib; reserved due to vascular risk. Mechanism: Potent multi-TKI; variant-dependent. Side effects: Arterial occlusion risk, hypertension; only in expert centers if benefits outweigh risks. Wikipedia

4. Topical/Intralesional Corticosteroids for Keloid-like Lesions (e.g., Triamcinolone)
   Purpose: Flatten and soften raised plaques; reduce itch/pain. Mechanism: Anti-inflammatory, anti-fibroblast. Use: Injections every 4–6 weeks or topical under dermatology care, often combined with silicone/pressure. Side effects: Skin atrophy, telangiectasia, hypopigmentation if overused. PMC

5. 5-Fluorouracil (Intralesional; often with Steroid)
   Purpose/Mechanism: Antimetabolite that reduces fibroblast proliferation in keloids. Use: Small serial injections into lesion by dermatology. Side effects: Ulceration, pain at site; expert technique required. PMC

6. Bleomycin (Intralesional)
   Purpose: Anti-fibrotic for refractory plaques. Caution: Risk of skin necrosis or systemic absorption; specialist-only. PMC

7. Verapamil (Intralesional)
   Purpose: Calcium-channel blocker that may reduce collagen deposition in keloids. Evidence: Mixed; sometimes second-line with steroid. Side effects: Local pain, rare systemic effects. PMC

8. Silicone-Based Topicals (Medical Device, not “drug,” but prescribed use)
   Purpose: First-line noninvasive option to flatten scars over months. Mechanism: Occlusion and hydration modulate collagen. Use: Daily wear of sheets or gels for 12–24 h/day per protocol. Safety: Very good; avoid on open wounds. PMCAAFP

9. NSAIDs (e.g., Naproxen)
   Purpose: Pain and activity tolerance for hand/foot discomfort. Mechanism: COX inhibition reduces prostaglandin-mediated pain. Caution: GI, renal, CV risks; use the lowest effective dose and gastroprotection if indicated.

10. Acetaminophen (Paracetamol)
    Purpose: Baseline analgesic with safer GI profile than NSAIDs (within dosing limits). Caution: Liver safety and total daily dose.

11. Bisphosphonates (e.g., Alendronate or IV Zoledronic Acid)
    Purpose: Improve bone mineral density and fracture prevention where osteoporosis coexists. Mechanism: Inhibit osteoclast-mediated bone resorption. Evidence in acro-osteolysis: May improve spine BMD and pain but do not reliably stop acro-osteolysis; use is individualized. Side effects: Rare jaw osteonecrosis (especially with dental disease), hypocalcemia; dental checks advised. PMCYonsei Medical JournalOrpha.net

12. Vitamin D (Rx strength when deficient)
    Purpose: Correct deficiency to support bone and muscle. Mechanism: Calcium absorption and bone turnover regulation. Use: Lab-guided replacement; monitor levels.

13. Topical Calcineurin Inhibitors (Tacrolimus) for Itchy Plaques (select cases)
    Purpose: Reduce itch/inflammation when steroids are unsuitable. Evidence: Off-label; dermatology-directed.

14. Antihistamines (Non-sedating by day, sedating at night if needed)
    Purpose: Reduce itch that worsens keloid rubbing/scratching.

15. Antibiotics (when secondary infection occurs)
    Purpose: Treat infected skin breaks or ulcers promptly to prevent scarring surge.

Targeted TKI therapy (imatinib/dasatinib) is the only disease-directed option with growing case-level evidence in PDGFRB-positive Penttinen syndrome; all other medicines are supportive or for complications. PubMed+1

---

Dietary Molecular Supplements

1. Vitamin D3 (800–2000 IU/day, lab-guided) – Supports calcium handling and bone turnover; low vitamin D worsens bone weakness.

2. Calcium (diet to ~1000–1200 mg/day total) – Builds bone mineral; pair with vitamin D for absorption. Avoid high supplemental doses if kidney stones risk.

3. Protein/Collagen Peptides (e.g., 20–30 g protein/meal; 5–10 g collagen peptides/day) – Supplies amino acids (glycine, proline) for collagen; may aid skin and tendon matrix repair.

4. Omega-3s (EPA+DHA 1–2 g/day) – Anti-inflammatory lipid mediators; may reduce scar itch/pain and support cardiovascular health.

5. Vitamin C (250–500 mg/day) – Co-factor for collagen cross-linking (prolyl/lysyl hydroxylases); supports wound healing.

6. Zinc (15–30 mg/day short course if deficient) – DNA repair and keratinocyte function; deficiency impairs healing.

7. Magnesium (200–400 mg/day) – Bone and muscle function; may reduce cramps from other therapies.

8. Vitamin K2 MK-7 (90–180 µg/day) – Activates osteocalcin and matrix Gla protein; supports bone mineral placement.

9. Orthosilicic Acid (≈5–10 mg Si/day) – Emerging support for collagen and bone matrix quality.

10. Curcumin (500–1000 mg/day with pepper extract) – Anti-inflammatory/anti-fibrotic signals in preclinical scar models; watch for drug interactions.

---

Regenerative/Stem-Cell” Drugs

• Important: There is no approved immune-booster or stem-cell drug for Penttinen syndrome. Items below are conceptual/adjunct in bone or fibrosis care and not disease-specific approvals.

1. Teriparatide (PTH 1-34) – Anabolic bone agent for severe osteoporosis; may improve BMD and reduce fractures; not shown to reverse acro-osteolysis. Daily injection; limit 2 years; avoid if malignancy risk.

2. Denosumab (RANKL inhibitor) – Potent antiresorptive; improves BMD; dental clearance needed given jaw osteonecrosis risk; unknown effect on acro-osteolysis.

3. Low-dose Sirolimus (mTOR inhibitor) – Antifibrotic/anti-proliferative signals explored in scar biology; careful monitoring; interaction with TKIs—specialist only.

4. PRP/Cell-based Wound Adjuncts – Used in chronic wound programs to enhance granulation; evidence variable; not disease-modifying.

5. Autologous Fat Grafting for Lipoatrophy Depressions – Regenerative soft-tissue filling; may improve cushion and skin quality; results vary.

6. Experimental PDGFR-Pathway Combinations – Clinical researchers sometimes combine imatinib with careful dermato-surgical scar care; participation in registries/trials is encouraged. PubMed

---

Surgical/Procedural Options

1. Keloid-like Plaque Excision with Adjuvant Therapy
   Excision alone often recurs. Combining surgery with post-op silicone/pressure and/or intralesional steroid/5-FU reduces recurrence. In select centers, superficial radiotherapy may be discussed. PMC

2. Laser/CO₂ or Pulsed-Dye Laser for Scar Remodeling
   Used to flatten and reduce redness/itch in thick plaques; often combined with medical scar care. PMC

3. Contracture Release & Z-Plasty/Tendon Procedures
   If tight skin and soft-tissue contractures limit hand opening or gait, plastic/hand surgeons can release and re-align tissue; therapy after surgery is key.

4. Orthopedic Stabilization for Painful Deformity/Instability
   Occasional arthrodesis or corrective procedures if distal joints collapse and conservative care fails.

5. Vascular/Aneurysm Repair (rare, case-based)
   PDGFRB-related phenotypes can include aneurysms; vascular surgery intervenes if surveillance detects significant lesions. PubMed

---

Prevention & Daily-Life Tips

1. Avoid repetitive pinch/grip on hard edges; use padded grips.

2. Use silicone and pressure on any new scars early. Lippincott Journals

3. Keep vitamin D replete; maintain protein intake.

4. Wear protective footwear; inspect feet daily.

5. Protect from cold; use gloves and hand warmers.

6. Practice sun/UV protection on thin skin.

7. Keep vaccines current; treat small wounds early.

8. Organize the home to prevent falls.

9. See dentist regularly; plan dental work around antiresorptives.

10. Keep regular follow-ups for bones, skin, and—if your team advises—vascular imaging. Orpha.net

---

When to see doctors urgently vs. routinely

• Urgent: New severe hand/foot pain or swelling after minor trauma; spreading redness, pus, or fever from a wound; sudden severe headache, neurologic symptoms, chest pain, or shortness of breath (to exclude vascular events); rapidly enlarging, ulcerating, or very painful skin plaque.

• Soon: New contracture limiting daily tasks; persistent ulcers; medication side effects (swelling, easy bruising, shortness of breath, palpitations).

• Routine: Regular check-ins with genetics/dermatology/orthopedics/physiotherapy; bone health monitoring; dental visits; and, when PDGFRB-positive, targeted-therapy monitoring schedules. PMC

---

What to eat and what to avoid

• Eat: Protein with each meal (eggs, fish, legumes) to support tissue repair.

• Eat: Calcium foods (dairy/fortified) plus vitamin-D sources; add leafy greens (vitamin K).

• Eat: Colorful fruits/vegetables (vitamin C, polyphenols) for collagen and antioxidant support.

• Eat: Omega-3-rich fish (2–3 times/week) or clinician-approved supplement.

• Hydrate: Enough water to keep skin comfortable and reduce cramps.

• Limit: Excess sugar and ultra-processed foods that promote inflammation.

• Limit: Alcohol and smoking (harm bone/skin healing).

• Caution: Very high vitamin A retinoids without medical guidance (bone effects).

• Caution: Herbal “scar cures” without evidence; discuss with your doctor, especially if on TKIs.

• Plan: If appetite is low, use small frequent meals or nutrition shakes with protein and micronutrients.

---

Frequently Asked Questions

1. Is this the same as “child progeria” (HGPS)?
   No. Some signs overlap, but Penttinen syndrome is usually caused by PDGFRB mutations and has keloid-like plaques and marked acro-osteolysis; HGPS is caused by LMNA/progerin. Genetic testing separates them. PMCNCBI

2. Can targeted medicine help?
   Yes—imatinib and sometimes dasatinib have helped some patients with PDGFRB mutations in case reports; this needs specialist care and monitoring. PubMed+1

3. Will bisphosphonates stop acro-osteolysis?
   They can improve bone density and pain, but generally do not stop the resorption at fingertips. PMC

4. Do keloid-like plaques always come back after surgery?
   Recurrence is common if surgery is done alone. Recurrence is lower when combined with silicone, pressure, and intralesional therapy. PMC

5. Is this inherited?
   It can be autosomal dominant (one changed gene copy enough), but many cases are new (de novo) in the person. A genetics team can explain family risk. UniProt

6. What tests are key?
   Hand/foot X-rays and PDGFRB genetic testing; then targeted screening guided by your team. PMC

7. Are there lifestyle changes that matter?
   Yes—joint protection, scar care with silicone/pressure, safe exercise, nutrition for bone/skin, and fall prevention make daily life easier. Lippincott Journals

8. Can children play sports?
   Usually yes, with low-impact choices and good protection; therapists can tailor plans.

9. What about pregnancy?
   Discuss genetics and medications (e.g., TKIs are generally avoided) with specialists before conception.

10. How often should scars be checked?
    Regular dermatology follow-up; new rapidly growing or ulcerating plaques should be seen promptly. PMC

11. Will hair grow back?
    Some PDGFRB-positive cases on imatinib reported improved hair growth, but results vary. Wiley Online Library

12. Can this affect blood vessels?
    Vascular changes (including aneurysms) have been described in PDGFRB-related disease; teams may suggest surveillance. PubMed

13. Is pain permanent?
    Pain often improves with joint protection, graded exercise, good footwear, and sensible analgesic plans.

14. Can school/work help?
    Yes—accommodations and ergonomic tools reduce hand strain and fatigue.

15. Where can we read more?
    Orphanet and Gene-centered resources (e.g., UniProt disease pages) are good starting points, and your genetics clinic can provide up-to-date guidance. Orpha.netUniProt

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 05, 2025.